$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much

Intellia Therapeutics (NASDAQ:NTLA) has outperformed the market over the past 5 years by 33.15% on an annualized basis.

Buying $100 In NTLA: 5 years ago, an investor could have purchased 7.51 shares of Intellia Therapeutics at the time with $100. This investment in NTLA would have produced an average annual return of 47.17%. Currently, Intellia Therapeutics has a market capitalization of $6.87 billion.